May 31 2010
Chakra Biotech Sdn Bhd today announced its name change to Cerca Insights Sdn Bhd. The name change follows the recent completion of a Series B investment round with Malaysian Life Sciences Capital Fund Ltd (MLSCF) and the Malaysian Technology Development Corporation Sdn Bhd (MTDC).
"The new name reinforces the value of our services," said Anthony Bishop, CEO of Cerca Insights. "Cerca, the Italian word for search, reflects our commitment to help pharma and biotech customers discover better medicines for patients, particularly those with psychiatric illness. Insights reflects our vision to provide customers a clear view of the clinical properties in their discovery stage compounds."
Cerca Insights continues to offer customers advanced, novel in-vivo efficacy models to discover, assess, and characterize discovery stage psychiatric and other CNS compounds.
Cerca Insights worked with Anderson Baillie Marketing in the UK to create the new name and branding.
SOURCE Cerca Insights Sdn Bhd